JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, K. Y.
Right arrow Articles by Hong, K. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, K. Y.
Right arrow Articles by Hong, K. W.

Vol. 300, Issue 2, 535-542, February 2002


Prevention of Lipopolysaccharide-Induced Apoptosis by (2S,3S,4R)-N"-Cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine, a Benzopyran Analog, in Endothelial Cells

Ki Young Kim, Byeong Gee Kim, Sun-Ok Kim, Sung-Eun Yoo, Yong-Geun Kwak, Soo-Wan Chae and Ki Whan Hong

Department of Pharmacology (K.Y.K., K.W.H.), College of Medicine and College of Natural Sciences (B.G.K.), Pusan National University, Pusan, Korea; Central Research Institute, Dongbu Hannong Chemical Co., Daejon, Korea (S.-O.K.); Research Institute of Chemical Technology, Daejon, Korea (S.-E.Y.); and Institute of Cardiovascular Research, Chonbuk National University, Chonju Korea (Y.-G.K., S.-W.C.)

    Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

This study describes the antiapoptotic action of (2S,3S,4R)-N"-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine (KR-31378), a novel benzopyran analog, in human umbilical vein endothelial cells (HUVECs) in comparison with its acetylated metabolite, (2S,3S,4R)-N"-cyano-N-(6-acetylamino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine (KR-31612), and with alpha -tocopherol. Exposure of HUVECs to lipopolysaccharide (LPS) (1 µg/ml) induced time- and concentration-dependent cytotoxicity and oligonucleosomal DNA fragmentation. KR-31378, KR-31612, and alpha -tocopherol potently suppressed LPS-induced cell death in association with significant reduction in the intracellular reactive oxygen species (ROS) and tumor necrosis factor-alpha (TNF-alpha ) that are stimulated by LPS. KR-31378 more effectively protected HUVECs from LPS-induced DNA fragmentation and was more effective in peroxyl radical scavenging than alpha -tocopherol. Incubation with LPS markedly decreased the Bcl-2 level, which was totally reversed by KR-31378 and to a lesser degree by KR-31612 and by alpha -tocopherol. In contrast, the greatly increased Bax protein and cytochrome c release stimulated by LPS were markedly suppressed by KR-31378 and by KR-31612, and to a lesser degree by alpha -tocopherol. Taken together, KR-31378 strongly inhibited cell death in HUVECs in association with antiapoptotic effects, which were accompanied by up-regulation of Bcl-2 protein expression and down-regulation of Bax protein and suppression of cytochrome c release. KR-31378 also showed the properties to scavenge the intracellular ROS and peroxyl radicals, and to reduce the TNF-alpha production induced by LPS.

    Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Vascular endothelial cell injury or activation by LPS plays a critical role in the pathogenesis of Gram-negative bacterial inflammation and endotoxic shock (Parrillo et al., 1990). LPS causes systemic release of TNF-alpha and both may mediate their deleterious effects by direct endothelial cell damage (Egido et al., 1993). TNF-alpha also induces the synthesis of ROS (Radeke et al., 1990). ROS are involved in cytokine-mediated signal transduction by interaction with biological macromolecules (e.g., nucleic acid) (Shaw et al., 1995), and apoptosis (Buttke and Sandstrom, 1994). The evidence that antioxidants attenuate the apoptosis further supported TNF-alpha -induced ROS formation (Huang et al., 1998; Lee et al., 1999). Thus, prevention of oxidative stress-mediated cell injury is an area of active investigation.

It is well established that the Bcl-2 family, consisting of antiapoptotic (e.g., Bcl-2 and Bcl-XL) and proapoptotic (e.g., Bax and Bad) members, plays an important role in the regulation of cell death. The former is known to prevent the release of cytochrome c to cytosol (Gross et al., 1999; Shimizu and Tsujimoto, 2000), whereas the latter members induce the release of cytochrome c from mitochondria and the activation of caspase cascade and apoptosis (Jürgensmeier et al., 1998). Thus, a number of studies have postulated that cell survival is associated with cell's ability to maintain a homeostatic level of Bcl-2.

Recently, (2S,3S,4R)-N"-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine (KR-31378) and (2S,3S,4R)-N"-cyano-N-(6-acetylamino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine (KR-31612), an acetyl metabolite, were synthesized by the Korea Research Institute of Chemical Technology, Daejon, Korea. In a previous study, we observed that KR-31378 effectively inhibited the increased cerebral infarct and swelling observed in rat cerebral cortex subjected to 2-h occlusion of middle cerebral artery and 24-h reperfusion. Furthermore, KR-31378 strongly inhibited lipid peroxidation in association with suppression of the electron paramagnetic resonance signals of superoxide anion and hydroxyl radicals, as did alpha -tocopherol.

In this study, we examined how KR-31378 suppressed the DNA fragmentation and consequent cell death in HUVECs in comparison with KR-31612 and with alpha -tocopherol. To identify the mechanism(s), we further evaluated their ability to scavenge peroxyl radicals, to suppress the LPS-stimulated hydrogen peroxide in HUVECs, and to evaluate the effect of these compounds on the expression of Bcl-2 and Bax protein, and on cytochrome c release from mitochondria in LPS-mediated apoptosis. alpha -Tocopherol was used as a reference agent.

    Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Cell Cultures. HUVECs [American Type Culture Collection (Manassas, VA), CRL-1730, endothelial cell line derived from the vein of normal human umbilical cord] were cultured in Kaighn's F12K medium supplemented with 10% heat-inactivated fetal bovine serum, 0.1 mg/ml heparin sodium, 0.03 to 0.05 mg/ml endothelial cell growth supplement, and 1% antibiotics (100 U/ml penicillin and 100 µg/ml streptomycin). Cells were grown to confluence at 37°C in 5% CO2 on 0.1% gelatin-coated culture dishes and used for experiments at no greater than passage 8.

Cell Viability Assay. For the mitochondrial tetrazolium assay (MTT) procedure, cells were seeded 1 × 104 cells/well in 96-well gelatin-coated tissue culture plates. The confluent cells received F12K medium with 1% fetal bovine serum plus drugs for 5 h before stimulation with LPS, and then were exposed to LPS for 18 h. After incubation, 20 µl/well of MTT solution (5 mg/ml phosphate-buffered saline) was added and incubated for 2 h. The plates were shaken for 20 min and the optical density measured at 570 to 630 nm by using enzyme-linked immunosorbent assay (Bio-Tek Instruments, Winooski, VT).

DNA Fragmentation Assays. After incubation in the absence and presence of the drugs for 5 h, cells (1-5 × 106) were exposed to LPS (1 µg/ml) for 18 h. At harvest, trypsinized cells were pelleted by centrifugation. Oligonucleosomal fragmentation of genomic DNA was determined as previously described (Wyllie, 1980). Cells were lysed in 1 ml of lysis buffer (10 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM EDTA, 1% sodium dodecyl sulfate, and 0.5 mg/ml proteinase K). Digestion was continued for 1 to 3 h at 55°C, followed by addition of RNase A to 0.1 mg/ml and running dye (10 mM EDTA, 0.25% bromophenol blue, 50% glycerol). Equivalent amounts of DNA (15-20 µg) were loaded into wells of 1.6% agarose gel and electrophoresed in 0.5× TAE buffer (40 mM Tris-acetate, 1 mM EDTA) for 2 h at 6 V/cm. DNA was visualized by ethidium bromide staining. Gel pictures were taken by UV transillumination with a Polaroid camera. Bands were quantified by Molecular Analyst Software by using Bio-Rad's Image Analysis System (Bio-Rad, Hercules, CA).

TNF-alpha Assay. Confluent cells incubated in the 48-well plates for 5 h in the absence and presence of the drugs and stimulated with 1 µM LPS for 18 h. TNF-alpha levels were assessed in supernatants by using a commercially available Quantikine M human TNF-alpha Immunoassay (R & D Systems, Minneapolis, MN), which is known to be cross-reactive with human TNF-alpha . TNF-alpha content was assessed by measuring absorbance at 450 nm by using enzyme-linked immunosorbent assay (Bio-Tek Instruments) and extrapolating from a standard curve.

Assay of Intracellular ROS. Measurement of intracellular ROS was based on ROS-mediated conversion of nonfluorescent 2',7'-dichlorofluororescine diacetate (DCFH-DA) into DCFH. The intensity of fluorescence reflects enhanced oxidative stress. To measure the intracellular ROS, confluent cells were preincubated for 5 h in the absence and presence of the drugs and then stimulated with LPS (1 µg/ml) for 18 h. Cells were incubated in the dark for 2 h at 37°C in 50 mM phosphate buffer, pH 7.4, containing 5 µM DCFH-DA. This agent is a nonpolar compound that readily diffuses into cells, where it is hydrolyzed to the fluorescent polar derivative DCFH and thereby trapped within the cells. The quantity of DCFH fluorescence was measured at an emission wavelength of 530 nm and an excitation wavelength of 485 nm by using Fluorescence Plate Reader (Bio-Tek Instruments). All experiments were repeated at least three times. Results were expressed as percentage of control fluorescence intensity.

Peroxyl Radical Absorbing Capacity (PRAC). The assay for peroxyl radical scavenging is based on production of peroxyl radicals by 2,2'-azobis(2-amidino-propane) dihydrochloride (AAPH) (3 mM) with subsequent oxidation of the reporter protein beta -phycoerythrin (beta -PE) (16.7 nM), in a volume of 2 ml with 75 mM phosphate buffer, pH 7.0, in 24-well plates. After adding AAPH, loss of fluorescence was measured every 5 min at the emission of 590 nm and excitation of 485 nm by using Fluorescence Plate Reader (Bio-Tek Instruments). Trolox (1 µM) was used as a reference for PRAC assay. The fluorescence just before addition of the AAPH was estimated as the 100% value for that sample. The PRAC values were calculated as follows: PRAC = [area of compound - area of blank]/[area of 1 µM trolox - area of blank], where 1 PRAC unit is the value of 1 µM trolox.

Western Blot Analyses. For determination of Bcl-2 and Bax protein levels, cells were grown in 100-mm tissue culture dishes and treated with the indicated compounds. After washing, the cells were lysed in lysis buffer containing 50 mM Tris-Cl, pH 8.0; 150 mM NaCl; 0.02% sodium azide; 100 µg/ml phenylmethylsulflonyl fluoride; 1 µg/ml aprotinin; and 1% Triton X-100. After centrifugation at 12,000 rpm, 50 µg of total protein of each sample was loaded into 12% SDS-polyacrylamide gel electrophoresis gel, and transferred to nitrocellulose membrane (Amersham Biosciences, Inc., Piscataway, NJ). The blocked membranes were then incubated with the antibody of Bcl-2 and Bax (Santa Cruz Biotechnology, Santa Cruz, CA).

Mitochondrial cytochrome c was prepared via the following procedures. After washing cells (12 × 106) once with ice-cold phosphate-buffered saline, cell pellets were resuspended in buffer A (20 mM HEPES-KOH, pH 7.5; 10 mM KCl; 1.5 mM MgCl2; 1 mM Na-EDTA; 1 mM Na-EGTA; 1 mM dithiothreitol; 0.1 mM phenylmethylsulfonyl fluoride) containing 250 mM sucrose. The cells were homogenized and then centrifuged twice at 750g for 10 min at 4°C. The harvested supernatants were centrifuged at 10,000g for 10 min at 4°C, and the resulting mitochondrial pellets were dissolved in 1× SDS sample buffer. Western blots were performed as described above with the antibody of cytochrome c (Santa Cruz Biotechnology). The immunoreactive bands were visualized using chemiluminescent reagent of the Supersignal West Dura Extended Duration Substrate kit (Pierce Chemical, Rockford, IL). The signals of the bands were quantified using the calibrated imaging densitometer (GS-710; Bio-Rad). The protein concentration of the lysate was determined using the Bio-Rad DC assay kit (Bio-Rad).

Chemicals. KR-31378 and KR-31612 (Korea Research Institute of Chemical Technology) were dissolved in dimethyl sulfoxide as a 10 mM stock solution. alpha -Tocopherol (Sigma-Aldrich, Seoul, Korea) was dissolved in ethanol (99%) as a 10 mM stock solution. Lipopolysaccharide (Sigma-Aldrich) was dissolved in distilled water as a 1-mg/ml stock solution. beta -PE (Sigma-Aldrich) and AAPH (Wako Pure Chemicals, Osaka, Japan) were dissolved in 75 mM phosphate buffer, pH 7.0. 3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide was from Sigma-Aldrich.

Statistical Analysis. The results are expressed as means ± S.E.M. Statistical differences between groups were determined by paired or unpaired Student's t test or analysis of variance. P < 0.05 was considered to be significant.

    Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Effect on Cell Viability. MTT assay measures the mitochondrial activity of viable cells. LPS showed time- (6-48 h) and concentration (1-1000 µg/ml)-dependent cytotoxic effect on HUVECs as determined by MTT assay in the culture medium. In the present study, cytotoxicity was examined after incubation with 1 µg/ml LPS for 18 h (Fig. 1, inset). After 18-h incubation, 1 µg/ml LPS reduced cell viability to 75.2% of control cells. Cell death was concentration-dependently prevented by simultaneous incubation with KR-31378, KR-31612, and alpha -tocopherol (10-8-10-4 M, each). After application of KR-31378 (10-4 M) in the absence of LPS, the cells showed 94.3 ± 2.7% viability, suggestive of lack of cytotoxicity.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 1.   Effects of KR-31378, KR-31612, and alpha -tocopherol on endothelial cell death induced by LPS. HUVECs (1 × 104 cells/well) were incubated with 1 µg/ml LPS for 48 h in the presence of fetal bovine serum, and cell viability was determined by MTT assay. KR-31378 and other drugs were added 5 h before LPS addition. Inset, time course of LPS (1 µg/ml)-induced cell death. Values are means ± S.E.M. of three different preparations with quadruplicate experiments. **, P < 0.01; ***, P < 0.001 versus vehicle.

Antiapoptotic Effect. Exposure of HUVECs to LPS (1 µg/ml) induced oligonucleosomal DNA fragmentation in time- and concentration-dependent manner, and the maximum values were obtained after 18 h of incubation. At 18 h after exposure to LPS, cells showed morphological characteristics of apoptosis, including cell shrinkage and chromatin condensation relative to control cells (data not shown). Treatment with KR-31378 strongly suppressed the LPS (1 µg/ml)-induced DNA laddering (P < 0.001), whereas KR-31612 and alpha -tocopherol showed significant but less suppression than KR-31378 (Fig. 2).


View larger version (66K):
[in this window]
[in a new window]
 
Fig. 2.   Top, representative agarose gel electrophoresis showing DNA laddering after exposure of HUVECs to 1 µg/ml LPS under pretreatment with vehicle (Veh), 10-5 M KR-31378 (378), 10-5 M KR-31612 (612), and 10-5 M alpha -tocopherol (alpha -TC). None represents absence of LPS. Preincubation of HUVECs with drugs for 5 h before and during LPS exposure significantly suppressed DNA laddering compared with LPS alone (Veh). M represents the 100-base pair DNA ladder markers. Bottom, results of densitometric analysis representing means ± S.E.M. from three experiments. **, P < 0.01; ***, P < 0.001 versus Veh; ###, P < 0.001 versus None.

Scavenging of Intracellular ROS and Peroxyl Radicals. The intracellular ROS concentration was determined by measuring the intensity of fluorescence. Incubation of DCFH-loaded cells in the medium containing LPS (0.01-10 µg/ml) for 18 h showed a concentration-dependent increase in fluorescence intensity. The intensity was 128.3 ± 3.8% by LPS at 1 µg/ml. KR-31378 and KR-31612 (10-8, 10-6, and 10-4 M) significantly suppressed the increased fluorescence stimulated by LPS (1 µg/ml) in a concentration-dependent manner, as did alpha -tocopherol (Fig. 3).


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 3.   Inhibitory effects of KR-31378, KR-31612, and alpha -tocopherol on the increased intracellular ROS stimulated by LPS (1 µg/ml) in HUVECs. Measurement of intracellular ROS was based on ROS-mediated conversion of nonfluorescent DCFH-DA into DCFH. KR-31378 and other drugs were added 5 h before and during exposure to LPS (1 µg/ml). Inset, LPS-concentration-dependent changes in fluorescence intensity indicative of intracellular ROS. Values are means ± S.E.M. from three different preparations with quadruplicate experiments. ##, P < 0.01; ###, P < 0.001 versus zero LPS; **, P < 0.01; ***, P < 0.001 versus vehicle (Veh).

Peroxyl radical absorbing ability of KR-31378 was identified by using beta -PE, where AAPH was used as a source of peroxyl radicals. In the presence of 10-6 and 10-4 M of KR-31378, the extinction curve showed a right shift, suggestive of its large scavenging effect (Fig. 4). The relative peroxyl radical absorbing capacity (in unit) calculated for KR-31378 (10-6 and 10-4 M) was 2.04 ± 0.45 (P < 0.01) and 3.25 ± 0.28 (P < 0.001) (Fig. 4, inset). The values of KR-31378 were significantly higher than those for alpha -tocopherol (10-6 and 10-4 M), indicating that KR-31378 possesses higher efficacy for scavenging peroxyl radical than alpha -tocopherol.


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 4.   Quenching of beta -PE with different concentrations of KR-31378 (378) and alpha -tocopherol (alpha -TC). Inset, PRAC values in unit. Each point represents mean ± S.E.M. of three measurements. *, P < 0.05; **, P < 0.01; ***, P < 0.001 versus 10-6 M trolox.

Effect on TNF-alpha Levels. The level of TNF-alpha in the control culture medium of HUVECs was 21.6 ± 3.4 pg/mg protein. Upon application of LPS (0.1-100 µg/ml) for 18 h, the TNF-alpha level was concentration-dependently increased as shown in Fig. 5, inset. TNF-alpha level stimulated by 1 µg/ml LPS was 383.4 ± 14.3 pg/ml, which was markedly suppressed by treatment with KR-31378 and KR-31612 (10-5 M, each) to 138.9 ± 5.5 (P < 0.001) and 152.2 ± 9.0 pg/ml (P < 0.01), respectively. alpha -Tocopherol (10-5 M) demonstrated a lower suppression (232.0 ± 14.5 pg/ml, P < 0.01) than KR-31378 (Fig. 5).


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 5.   Inhibitory effects of KR-31378 (378), KR-31612 (612), and alpha -tocopherol (alpha -TC) on LPS (1 µg/ml)-induced TNF-alpha release from HUVECs. Inset, concentration-dependent LPS-induced TNF-alpha release. Values are means ± S.E.M. from three different preparations with triplicate experiment. ##, P < 0.01; ###, P < 0.001 versus zero LPS; **, P < 0.01; ***, P < 0.001 versus vehicle.

Western Blot Analyses. Figure 6 shows the concentration-dependent levels of Bcl-2 and Bax protein, and release of cytochrome c in the absence and presence of LPS (0, 0.5, 1, and 5 µg/ml). In the absence of LPS, Bcl-2 protein was present in high levels (control samples, relative density = 1), and Bax protein was at very low levels (control, relative density = 1). In contrast, cytochrome c release was not manifested in the control cells. Both Bax level and cytochrome c release were significantly elevated with increasing concentrations of LPS from 0.5 to 5 µg/ml, whereas Bcl-2 level was concentration-dependently decreased.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 6.   Graphs showing the densitometric analysis of Western blot for the expression of Bcl-2, Bax levels, and cytochrome c release in the presence of different concentrations of LPS (0-5 µg/ml) in HUVECs. Both Bax protein and cytochrome c release were significantly elevated with increasing concentrations of LPS from 0.5 to 5 µg/ml, whereas high levels of Bcl-2 in control samples were concentration-dependently decreased. Values are means ± S.E.M. from three different experiment. ***, P < 0.001 (Bcl-2); ##, P < 0.01; ###, P < 0.001 (Bax); dagger dagger dagger , P < 0.001 (cytochrome c) versus zero LPS.

LPS (1 µg/ml)-induced suppression of Bcl-2 level was down to 0.15 ± 0.05 relative density, which was recovered in a concentration-dependent manner by pretreatment with KR-31378 (10-6, 10-5, and 10-4 M) to 0.56 ± 0.07, 0.76 ± 0.1, and 0.98 ± 0.07 relative density, respectively. The last level indicates total restoration of Bcl-2 protein (Fig. 7A). The suppressed Bcl-2 level was also reversed by KR-31612 and alpha -tocopherol (10-5 M, each), but to a lower degree than KR-31378 (10-5 M) (Fig. 7B).


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 7.   Representative Western blots of HUVEC homogenates for Bcl-2 protein and the corresponding densitometric analysis. Effects of KR-31378 and other two compounds on LPS (1 µg/ml)-induced suppression of Bcl-2 protein levels were observed. A, LPS-induced decreased Bcl-2 level was wholly recovered by KR-31378 in a concentration-dependent manner. B, KR-31378 (378, 10-5 M) and to a less degree by KR-31612 (612, 10-5 M) and alpha -tocopherol (alpha -TC, 10-5 M) fully reversed the LPS-induced decreased Bcl-2 level. Values are means ± S.E.M. from three different experiments. **, P < 0.01; ***, P < 0.001 versus vehicle (Veh).

In contrast, the Bax protein level was markedly increased in a concentration-dependent manner in the presence of 1 µg/ml LPS to 9.88 ± 1.70 relative density, which was strongly suppressed by KR-31378 (10-6-10-4 M) in a concentration-dependent manner (Fig. 8A). KR-31612 and alpha -tocopherol (10-5 M, each) also significantly decreased the Bax protein level (Fig. 8B).


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 8.   Representative Western blots of HUVEC homogenates for Bax protein and the corresponding densitometric analysis. Effects of KR-31378 and other two compounds on LPS (1 µg/ml)-induced increase in Bax protein level were observed. A, LPS-induced increased Bax level was markedly inhibited by KR-31378 in a concentration-dependent manner. B, KR-31378 (378, 10-5 M) and KR-31612 (612, 10-5 M), but to a less degree by alpha -tocopherol (alpha -TC), suppressed the LPS-induced Bax level. Values are means ± S.E.M. from three different experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001 versus vehicle (Veh).

Because cytochrome c release was not identified in the control cultures, the level of LPS (1 µg/ml)-induced cytochrome c release was expressed as 100%. The cytochrome c release from mitochondria was significantly and concentration-dependently suppressed by KR-31378 (10-6-10-4 M) as shown in Fig. 9A. KR-31612 showed a similar inhibitory activity, as did KR-31378, but alpha -tocopherol at 10-5 M concentration showed weak inhibition (Fig. 9B).


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 9.   Representative Western blots of HUVEC homogenates for cytochrome c release and the corresponding densitometric analysis. Effects of KR-31378 and other two compounds on LPS (1 µg/ml)-induced increase in cytochrome c release into cytosol. A, LPS-induced increased cytochrome c release was markedly inhibited by KR-31378 in a concentration dependent manner. B, KR-31378 (378, 10-5 M) and KR-31612 (612, 10-5 M), but to a less degree by alpha -tocopherol (alpha -TC), inhibited the LPS-induced increased cytochrome c level. Values are means ± S.E.M. from three different experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001 versus vehicle (Veh).

    Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

In the present study, the major findings were that 1) KR-31378 effectively protected HUVECs from LPS-induced cell death accompanied by oligonucleosomal DNA fragmentation; 2) KR-31378 and KR-31612 significantly reduced the increased production of intracellular ROS and TNF-alpha that are stimulated by LPS, and KR-31378 more effectively scavenged peroxyl radical than alpha -tocopherol; and 3) incubation with LPS markedly decreased the Bcl-2 protein and increased the Bax protein in association with increase in cytochrome c release, which was significantly reversed by KR-31378 and to a lesser degree by KR-31612 and by alpha -tocopherol.

LPS, a bacterial endotoxin, is a proinflammatory mediator that induces the production of significant amounts of endogenous TNF-alpha , and both may mediate endothelial cell damage (Egido et al., 1993). The importance of TNF-alpha and ROS endogenously released after exposure to LPS has been associated with the genesis of apoptosis and cell death (Böhler et al., 2000). TNF-alpha also may activate a cell survival pathway that protects against its apoptotic effects (Karsan et al., 1996) and HUVECs are demonstrated to hardly undergo programmed cell death in response to TNF-alpha alone (Polunovsky et al., 1994). Therefore, in the present study, LPS was used as an inducer of apoptosis instead of TNF-alpha .

In our results, LPS-induced cytotoxicity as determined by MTT assay was concentration-dependently suppressed by incubation of HUVECs with 10-8 to 10-4 M of KR-31378, KR-31612 as well as was by alpha -tocopherol. The cell death was accompanied by DNA fragmentation in a time- and concentration-dependent manner. Treatment with KR-31378 strongly suppressed the LPS (1 µg/ml)-induced DNA laddering. Under incubation of HUVECs with LPS, both intracellular ROS and TNF-alpha significantly and concentration-dependently increased in the HUVECs. The current results of suppression of ROS and peroxyl radicals by KR-31378 and the chemical properties of KR-31378 to scavenge not only the hydroxyl radical but also superoxide anion highlighted the ability of KR-31378 to react with a wide spectrum of radicals.

In the pilot study, KR-31378 did not exert any effect on the action potential duration in the ventricular myocytes as contrasted to pinacidil, an ATP-sensitive K+ channels. KR-31378, however, showed opening of large conductance Ca2+-activated K+ channels (maxi-K channels) in isolated vascular myocytes of rat basilar artery, which was not blocked by glibenclamide (ATP-sensitive K+ channel blocker) but by iberiotoxin (large conductance Ca2+-activated K+ channel blocker). Because maxi-K channels are present in many brain regions, including the cortex and hippocampus (Knaus et al., 1996) and maxi-K channels have been identified in endothelial cells (Rusko et al., 1992), it is thus predictable that, when opened, maxi-K channels may reduce voltage-dependent Ca2+ entry into the cells after restoration of membrane potential (Latorre et al., 1989). At present time, it is undetermined whether suppression of LPS-induced TNF-alpha production and DNA fragmentation by KR-31378 are attributable to the opening of maxi-K channels and to the reduction in intracellular Ca2+ accumulation. Although the ability of KR-31378 to open maxi-K channels provided a satisfactory explanation for its efficacy in protecting cells against LPS insults, it was unclear whether this mechanism was also involved in suppression of TNF-alpha formation or secretion. Future study will be required to address this issue.

KR-31378 suppressed LPS-induced increased TNF-alpha levels. It is considered that KR-31378 might inhibit the LPS-induced cell death with DNA fragmentation by a dual pathway: 1) inhibition of synthesis and/or action of TNF-alpha , and 2) inhibition of oxidative stress. LPS has been demonstrated to induce apoptosis in bovine endothelial cells via a soluble CD14-dependent pathway (Frey and Findlay, 1998). However, it is undefined whether LPS-induced apoptosis in HUVECs is mediated through its interaction with soluble CD14. K+ channel openers, including diazoxide and levcromakalim, protected cultured rat hippocampal neurons against oxidative injury induced by exposure to FeSO4 and amyloid beta -peptide by suppressing the generation of peroxides, even in the presence of the K+ channel blockers glibenclamide and 4-aminopyridine (Goodman and Mattson, 1996). They suggested that the protective mechanism of K+ channel openers involves antioxidant cell protective action other than K+ channel opening effect. Most recently, Sanlioglu et al. (2001) further emphasized the importance of ROS in the TNF-alpha secretion after LPS challenge in macrophages. They demonstrated that Rac1 (a GTP-binding protein) activation-linked ROS formation constituted a major pathway involved in nuclear factor-kappa B-mediated TNF-alpha secretion independent of CD14. Based on these reports, it is likely that the reduction in TNF-alpha formation under incubation of HUVECs with KR-31378 is attributable to the high antioxidant potency of KR-31378.

alpha -Tocopherol is known as biologically and chemically the most active form of vitamin E and as a lipid peroxyl radical trapping and chain-breaking antioxidant. Although data are not shown, KR-31378 showed no pro-oxidant effect in contrast to alpha -tocopherol (Neuzil et al., 1997).

On the other hand, apoptosis is introduced as a regulated series of energy-dependent molecular and biochemical processes orchestrated by a genetic program (Hale et al., 1996). ROS, including hydrogen peroxide and hydroxyl radical, and lipid hydroperoxides are all importantly implicated in the processes of apoptosis as second messengers in the cytokine (i.e., TNF-alpha and IL-1alpha )-induced apoptosis (Kroemer et al., 1995; Li et al., 1997). Accumulating evidence points to a significant role for Bcl-2 and its family of cell death-regulating proteins in promoting cell survival and cell death (Bredesen, 1995). Martinou (1999) suggested that overexpression of Bcl-2 in transgenic mice appears to protect neurons from ischemia-induced cell death. Conversely, a decrease in immunoreactivity of Bcl-2 and increase in Bax protein contributing to neuronal apoptosis were observed in neurons within ischemic cortex and thalamus (Gillardon et al., 1996). Haendeler et al. (1996) have discussed the regulation of the Bcl-2 protein family by demonstrating that the antioxidant N-acetylcysteine and the combination of vitamin C and E (10 µM) inhibited LPS-induced apoptosis, and the reduction of LPS-induced apoptosis by vitamin C and E was paralleled by an increase in Bcl-2 and a decrease in Bax protein levels. These results indicate that cell survival is associated with the ability of cells to maintain high levels of Bcl-2. Consistent with these reports, our results showed that KR-31378 totally restored the suppressed Bcl-2 levels induced by LPS. These are well correlated with inhibition of DNA fragmentation by KR-31378 as assessed by DNA ladder pattern on agarose electrophoresis. On the other hand, Bax is one of the Bcl-2 family homologous to Bcl-2, and Bcl-2 heterodimerizes with Bax, which accelerates programmed cell death (Oltvai et al., 1993). Bax was envisioned as a cell death effector whose activity is neutralized by binding with Bcl-2 (Sato et al., 1994).

Recent studies have implicated mitochondria as an important regulatory site of the apoptotic process (Kroemer, 1998) and the rise of cytochrome c release from mitochondria to cytosol as one of the main pathways governing apoptosis (Zhang et al., 2000). It was suggested that Bcl-2 and Bcl-XL prevented the loss of the mitochondrial membrane potential and the release of cytochrome c to cytosol (Gross et al., 1999), whereas Bax promoted apoptosis by triggering the release of cytochrome c from mitochondria, activating caspase cascade (Jürgensmeier et al., 1998). ROS produced endogenously are known to enhance the permeability of the mitochondrial membrane and the release of cytochrome c to the cytosol (Marzo et al., 1998; Shimizu et al., 1999). As shown in the profile of Bax, LPS-induced up-regulation of cytochrome c release was also significantly reduced by KR-31378 and to a less degree by KR-31612. It remains, however, undetermined in the present study whether Bax stimulates cytochrome c release and whether Bcl-2 acts primarily at the mitochondria to prevent Bax-mediated cytochrome c.

Taken together, KR-31378 and its acetyl metabolite KR-31612 exert a strong antiapoptotic effect in HUVECs with scavenging of intracellular ROS and peroxyl radicals, and with reduction of TNF-alpha production, thereby eliciting up-regulation of Bcl-2 levels and down-regulation of Bax levels and cytochrome c release.

    Acknowledgments

We are grateful to Jonathan Kaskin for reading and commenting on the manuscript.

    Footnotes

Accepted for publication November 2, 2001.

Received for publication August 9, 2001.

This study was supported with funding from the Center for Bioactive Substances, Korea Research Institute of Chemical Technology, Daejon, and from the Korea Science and Engineering Foundation, Korea.

Address correspondence to: Dr. Ki Whan Hong, Department of Pharmacology, College of Medicine, Pusan National University, 10 Ami-Dong, 1-Ga, Seo-Gu, Pusan 602-739, Korea. E-mail: kwhong{at}hyowon.pusan.ac.kr

    Abbreviations

LPS, lipopolysaccharide; TNF-alpha , tumor necrosis factor-alpha ; ROS, reactive oxygen species; HUVEC, human umbilical vein endothelial cell; MTT, mitochondrial tetrazolium; DCFH-DA, 2',7'-dichlorofluororescine diacetate; DCFH, 2',7'-dichlorofluororescine; PRAC, peroxyl radical absorbing capacity; AAPH, 2,2'-azobis(2-amidino-propane) dihydrochloride; beta -PE, beta -phycoerythrin.

    References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References


0022-3565/02/3002-0535-0542$03.00
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Immunol.Home page
H. L. Wang, I. O. Akinci, C. M. Baker, D. Urich, A. Bellmeyer, M. Jain, N. S. Chandel, G. M. Mutlu, and G. R. S. Budinger
The Intrinsic Apoptotic Pathway Is Required for Lipopolysaccharide-Induced Lung Endothelial Cell Death
J. Immunol., August 1, 2007; 179(3): 1834 - 1841.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
F. Porta, J. Takala, C. Weikert, P. Kaufmann, S. Krahenbuhl, and S. M. Jakob
Effect of endotoxin, dobutamine and dopamine on muscle mitochondrial respiration in vitro
Innate Immunity, December 1, 2006; 12(6): 358 - 366.
[Abstract] [PDF]


Home page
BloodHome page
F. Wong, C. Hull, R. Zhande, J. Law, and A. Karsan
Lipopolysaccharide initiates a TRAF6-mediated endothelial survival signal
Blood, June 15, 2004; 103(12): 4520 - 4526.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. D. Bannerman and S. E. Goldblum
Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis
Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L899 - L914.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. W. Hong, K. Y. Kim, J. H. Lee, H. K. Shin, Y. G. Kwak, S.-O. Kim, H. Lim, and S.-E. Yoo
Neuroprotective Effect of (2S,3S,4R)-N""-cyano-N-(6-amino-3, 4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine (KR-31378), a Benzopyran Analog, against Focal Ischemic Brain Damage in Rats
J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 210 - 216.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, K. Y.
Right arrow Articles by Hong, K. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, K. Y.
Right arrow Articles by Hong, K. W.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition